Physician profile
Christopher Charles
NPI 1073594743
$1,628.53
in general payments reported to CMS, 2019-2025
16 companies · $363 in 2025
The $363 reported for 2025 was more than what 89% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $174 · 2021: $170 · 2022: $90.89 · 2023: $154 · 2024: $333 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $850.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $417.01 | 2019-2024 | |
| Glaxosmithkline, LLC. | $153.25 | 2019-2024 | Bexsero, Pediarix, Menveo |
| Supernus Pharmaceuticals, INC. | $148.87 | 2021-2025 | Qelbree |
| Merck Sharp & Dohme LLC | $143.65 | 2019-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Sanofi Pasteur INC. | $135.56 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $132.01 | 2020-2021 | |
| Corium, LLC | $125.67 | 2022-2025 | Azstarys |
| Regeneron Healthcare Solutions, INC. | $108.47 | 2024-2025 | Dupixent |
| Pfizer INC. | $89.57 | 2025 | |
| Neos Therapeutics, Lp | $42.95 | 2019-2020 | |
| Tris Pharma INC | $39.00 | 2020-2023 | Dyanavel Xr |
| Collegium Pharmaceutical, INC. | $30.10 | 2025 | Jornay Pm |
| Roche Diagnostics Corporation | $19.52 | 2025 | Navify Poc Operations |
| Mission Pharmacal Company | $17.36 | 2019 | |
| Quidel Corporation | $13.24 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $12.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Charles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.